Long-standing debate over metformin's primary target resolved by new findings

Researchers have identified the main mechanism of the widely used diabetes drug metformin, settling a long-standing question about whether it acts primarily in the intestines or the liver. The new evidence points to the intestines as the key site of action, clarifying how the medication lowers blood sugar. This insight could inform future diabetes treatments and drug development.